CGON compared with AKTS: revenue, margins and what each company keeps, and the suppliers and customers both name

CGONCG Oncology, Inc.

Mkt capRevenueRevenue

AKTSAktis Oncology, Inc.

Mkt capRevenueRevenue

Compare

CGONCG Oncology, Inc.

AKTSAktis Oncology, Inc.

Price

Mkt cap

Revenue

Co-movers

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

daily closes · 188dMethod ›

Moved together

CGONwithAKTS

×0.50co-movement · AKTS on CGON · 188d

r 0.36scale to r 0.75

Shared co-movers1with CGONwith AKTS

NRIXNurix Therapeutics, Inc.r 0.44r 0.34

CGON, solidAKTS, hatched× = co-movement · βr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

CGONCG Oncology, Inc.

67.78▲+5.81%· post 68.50· delayed

Mkt cap$5.7BRevenue$1MQ2 FY26

AKTSAktis Oncology, Inc.

15.11▲+1.13%· post 15.11· delayed

After hoursNov 4 '26delayed

Mkt cap$826.2MRevenue$3MQ2 FY26

Compare

After hoursNov 4 '26delayed

CGONCG Oncology, Inc.

AKTSAktis Oncology, Inc.

67.78▲+5.81%post 68.50delayed

Price

15.11▲+1.13%post 15.11delayed

$5.7B

Mkt cap

$826.2M

Q2 FY26$1M

Revenue

$3MQ2 FY26

CGON67.78▲+5.81%vsAKTS15.11▲+1.13%After hoursNov 4 '26delayed